p21 PIP盒的酸化水平调节活细胞中与PCNA的相互作用
Christian Melle1, Birgit Hoffmann1, Annett Wiesenburg1
1Biomolecular Photonics Group, Jena University Hospital, Friedrich Schiller University Jena, Jena, 07740, Germany.
Biochemical and biophysical research communications
|February 22, 2026
概括
细胞循环调节器p21 (CDKN1A) 的酸化影响其与增殖细胞核抗原 (PCNA) 的相互作用. 在p21中同时酸化T145和S146.
科学领域:
- 分子生物学分子生物学
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 蛋白质通过复合体内的相互作用来起作用.
- 增殖细胞核抗原 (PCNA) 和p21 (CDKN1A) 是细胞周期进展的关键调节剂.
- 了解它们的相互作用对于细胞周期控制至关重要.
研究的目的:
- 为了研究p21转录后修改对其与PCNA在活细胞中的相互作用的影响.
- 确定p21的PCNA相互作用蛋白盒 (PIP盒) 中特定位点的酸化如何影响结合亲和力.
- 阐明p21酸化在调节PCNA-p21复合体形成中的作用.
主要方法:
- 使用基于光终身成像显微镜 (FLIM) 的Förster共振能量转移 (FRET) 测量.
- 采用位点定向的突变发生,以产生酸化模仿和酸化阻止的p21变体.
- 使用p21变体与删除的PIP盒 (p21ΔPIP) 进行研究的相互作用.
主要成果:
- 在p21的PIP盒中同时化threonine145和serine146显著降低了FRET的效率,表明PCNA相互作用减弱.
- 致变酶阻止T145和S146的酸化到氨酸提高了FRET的效率,这意味着PCNA-p21相互作用更强.
- 删除p21ΔPIP中的PIP框限制了它与PCNA的相互作用.
结论:
- p21的PIP盒的酸化状态是其与PCNA相互作用的关键调节者.
- 在生理条件下,特定的酸化模式调节p21变体和PCNA之间的结合亲和力.
- 这一规则提供了一种通过PCNA-p21复杂动态来控制细胞周期进展的机制.
相关概念视频
Phosphoinositides and PIPs
10.4K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
10.4K
Inhibition of Cdk Activity
6.1K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.1K
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
Interactions Between Signaling Pathways
7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
Positive Regulator Molecules
7.0K
Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
7.0K


